Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein

American Journal of Pathology

Volumn 151, Issue 3, 1997, Pages 735-744

  Kuroda, Masahiko ^a,b   Ishida, Tsuyoshi ^b   Takanashi, Masakatsu ^b   Satoh, Mayumi ^c   Machinami, Rikuo ^b   Watanabe, Toshiki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPSIN; CHIMERIC PROTEIN; INSULIN; THIAZOLIDINE DERIVATIVE;

ADIPOCYTE; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CHROMOSOME TRANSLOCATION 12; CONTACT INHIBITION; DNA FLANKING REGION; GENE EXPRESSION; MALIGNANT TRANSFORMATION; MOUSE; MYXOSARCOMA; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING; TRANSCRIPTION REGULATION;

ADIPOCYTES; ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION; INSULIN; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; RNA-BINDING PROTEIN FUS; THIAZOLES; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; TRANSFORMATION, GENETIC;

EID: 0030882823     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Mitelman F (ed): Catalog of Chromosome Aberrations in Cancer, ed 5. New York, Wiley-Liss, 1994
2. Rabbitts TH: Chromosomal translocations in human cancer. Nature 1994, 372:143-149
3. Rabbitts TH, Forster A, Larson R, Nathan P: Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nature Genet 1993, 4:175-180
4. Crozat A, Aman P, Mandahl N, Ron D: Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993, 363:640-644
5. Ron D, Habener JF: CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 1992, 6:439-453
6. Gerald WL, Rosai J, Ladanyi M: Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc Natl Acad Sci USA 1995, 92:1028-1032
7. Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc CC, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G, Delattre O: Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 1993, 12:4481-4487
8. Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, Fletchers CD, Aurias A, Thomas G: EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nature Genet 1993, 4:341-345
9. Panagopoulos I, Hoglund M, Mertens F, Mandahl N, Mitelman F, Aman P: Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 1996, 12:489-494
10. Panagopoulos I, Mandahl N, Ron D, Hoglund M, Nilbert M, Mertens F, Mitelman F, Aman P: Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. Cancer Res 1994, 54:6500-6503
11. Knight JC, Renwick PJ, Cin PD, Van den Berghe H, Fletcher CD: Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res 1995, 55:24-27
12. Kuroda M, Ishida T, Horiuchi H, Kida N, Uozaki H, Takeuchi H, Tsuji K, Imamura T, Mori S, Machinami R, Watanabe T: Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. Am J Pathol 1995, 147:1221-1227
13. Sanchez GI, Rabbitts TH: Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. Proc Natl Acad Sci USA 1994, 91:7869-7873
14. Zinszner H, Albalat R, Ron D: A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev 1994, 8:2513-2526
15. Watt FM: Cell culture models of differentiation. FASEB J 1991, 5:287-294
16. Taylor SM, Jones PA: Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 1979, 17:771-779
17. Weintraub H, Davis R, Tapscott S, Thayer M, Krause M, Benezra R, Blackwell TK, Turner D, Rupp R, Hollenberg S, Zhuang Y, Lassar A: The myoD gene family: nodal point during specification of the muscle cell lineage. Science 1991, 251:761-766
18. Sager R, Kovac P: Pre-adipocyte determination either by insulin or by 5-azacytidine. Proc Natl Acad Sci USA 1982, 79:480-484
19. Cornelius P, MacDougald OA, Lane MD: Regulation of adipocyte development. Annu Rev Nutrition 1994, 14:99-129
20. Hiragun A: New Perspectives in Adipose Tissue: Structure, Function and Development. Edited by A Cryer, RLR Van. London, Butterworths, 1985
21. Samuelsson L, Stromberg K, Vikman K, Bjursell G, Enerback S: The CCAAT/enhancer binding protein and its role in adipocyte differentiation: evidence for direct involvement in terminal adipocyte development. EMBO J 1991, 10:3787-3793
22. Umek RM, Friedman AD, McKnight SL: CCAAT-enhancer binding protein: a component of a differentiation switch. Science 1991, 251: 288-292
23. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156
24. Lin FT, MacDougald OA, Diehl AM, Lane MD: A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc Natl Acad Sci USA 1993, 90:9606-9610
25. Freytag SO, Paielli DL, Gilbert JD: Ectopic expression of the CCAAT/ enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev 1994, 8:1654-1663
26. Lin FT, Lane MD: CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 1994, 91:8757-8761
27. Batchvarova N, Wang XZ, Ron D: Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J 1995, 14:4654-4661
28. Hiragun A, Sato M, Mitsui H: Establishment of a clonal cell line that differentiates into adipose cells in vitro. In Vitro 1980, 16:685-693
29. Green H, Kehinde O: An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 1975, 5:19-27
30. Negrel R, Grimaldi P, Ailhaud G: Establishment of preadipocyte clonal line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones. Proc Natl Acad Sci USA 1978, 75:6054-6058
31. Hiragun A, Sato M, Mitsui H: Preadipocyte differentiation in vitro: identification of a highly active adipogenic agent. J Cell Physiol 1988, 134:124-130
32. Sparks RL, Strauss EE, Zygmunt AI, Phelan TE: Antidiabetic AD4743 enhances adipocyte differentiation of 3T3 T mesenchymal stem cells. J Cell Physiol 1991, 146:101-109
33. Kletzien RF, Clarke SD, Ulrich RG: Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol Pharmacol 1992, 41: 393-398
34. Sandouk T, Reda D, Hofmann C: Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol 1993, 264:C1600-C1608
35. Sohda T, Meguro K, Kawamatsu Y: Studies on antidiabetic agents. IV. Synthesis and activity of the metabolites of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (ciglitazone). Chem Pharm Bull 1984, 32:2267-2278
36. Thompson SW: Selected Histochemical and Histopathological Methods. Edited by CC Thomas. Springfield, 1966
37. Tatewaki M, Yamaguchi K, Matsuoka M, Ishii T, Miyasaka M, Mori S, Takatsuki K, Watanabe T: Constitutive overexpression of the L-selectin gene in fresh leukemic cells of adult T-cell leukemia that can be transactivated by human T-cell lymphotropic virus type I Tax. Blood 1995, 86:3109-3117
38. Timchenko N, Wilson DR, Taylor LR, Abdelsayed S, Wilde M, Sawadogo M, Darlington GJ: Autoregulation of the human C/EBP alpha gene by stimulation of upstream stimulatory factor binding. Mol Cell Biol 1995, 15:1192-1202
39. Antonson P, Xanthopoulos KG: Molecular cloning, sequence, and expression patterns of the human gene encoding CCAAT/enhancer binding protein alpha (C/EBP alpha). Biochem Biophys Res Commun 1995, 215:106-113
40. Purschke WG, Muller PK: An improved fluor diffusion assay for chloramphenicol acetyltransferase gene expression. Biotechniques 1994, 16:264-265
41. Herbomel P, Bourachot B, Yaniv M: Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 1984, 39:653-662
42. Christy RJ, Yang VW, Ntambi JM, Geiman DE, Landschulz WH, Friedman AD, Nakabeppu Y, Kelly TJ, Lane MD: Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev 1989, 3:1323-1335
43. Herrera R, Ro HS, Robinson GS, Xanthopoulos KG, Spiegelman BM: A direct role for C/EBP and the AP-I-binding site in gene expression linked to adipocyte differentiation. Mol Cell Biol 1989, 9:5331-5339
44. Cao Z, Umek RM, McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991, 5:1538-1552
45. Bernlohr DA, Angus CW, Lane MD, Bolanowski MA, Kelly TJ Jr: Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. Proc Natl Acad Sci USA 1984, 81:5468-5472
46. Cook KS, Hunt CR, Spiegelman BM: Developmentally regulated mRNAs in 3T3-adipocytes: analysis of transcriptional control. J Cell Biol 1985, 100:514-520
47. Hunt CR, Ro JH, Dobson DE, Min HY, Spiegelman BM: Adipocyte P2 gene: developmental expression and homology of 5′-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci USA 1986, 83:3786-3790
48. Min HY, Spiegelman BM: Adipsin, the adipocyte serine protease: gene structure and control of expression by tumor necrosis factor. Nucleic Acids Res 1986, 14:8879-8892
49. Lin FT, Lane MD: Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev 1992, 6:533-544
50. Barone MV, Crozat A, Tabaee A, Philipson L, Ron D: CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev 1992, 8:453-464
51. Freytag SO, Geddes TJ: Reciprocal regulation of adipogenesis by Myc and C/EBPα. Science 1992, 256:379-382
52. Pegano M, Theodoras AM, Tam SW, Draetta GF: Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev 1994, 8:1627-1639
53. Prasad DDK, Ouchida M, Lee L, Rao VN, Reddy SP: TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 1994, 9:3717-3729